These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

304 related items for PubMed ID: 7755506

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Development of HIV/AIDS vaccine using chimeric gag-env virus-like particles.
    Kang CY, Luo L, Wainberg MA, Li Y.
    Biol Chem; 1999 Mar; 380(3):353-64. PubMed ID: 10223338
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Construction, expression, and immunogenicity of chimeric HIV-1 virus-like particles.
    Wagner R, Deml L, Schirmbeck R, Niedrig M, Reimann J, Wolf H.
    Virology; 1996 Jun 01; 220(1):128-40. PubMed ID: 8659105
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Progress toward an artificial vaccine for HIV: identification of helper and cytotoxic T-cell epitopes and methods of immunization.
    Berzofsky JA.
    Biotechnol Ther; 1991 Jun 01; 2(1-2):123-35. PubMed ID: 1726961
    [Abstract] [Full Text] [Related]

  • 8. Recognition of two overlapping CTL epitopes in HIV-1 p17 by CTL from a long-term nonprogressing HIV-1-infected individual.
    Harrer T, Harrer E, Barbosa P, Kaufmann F, Wagner R, Brüggemann S, Kalden JR, Feinberg M, Johnson RP, Buchbinder S, Walker BD.
    J Immunol; 1998 Nov 01; 161(9):4875-81. PubMed ID: 9794421
    [Abstract] [Full Text] [Related]

  • 9. Enhancement of cellular and humoral immune responses to human immunodeficiency virus type 1 Gag and Pol by a G/P-92 fusion protein expressing highly immunogenic Gag p17/p24 and Pol p51 antigens.
    Kmieciak D, Bolesta E, Naito T, Gzyl J, Kaneko Y, Kozbor D.
    J Hum Virol; 2001 Nov 01; 4(6):306-16. PubMed ID: 12082397
    [Abstract] [Full Text] [Related]

  • 10. An HIV-1 envelope protein vaccine elicits a functionally complex human CD4+ T cell response that includes cytolytic T lymphocytes.
    Stanhope PE, Liu AY, Pavlat W, Pitha PM, Clements ML, Siliciano RF.
    J Immunol; 1993 May 15; 150(10):4672-86. PubMed ID: 8097759
    [Abstract] [Full Text] [Related]

  • 11. Simian immunodeficiency virus as a model for vaccination against HIV. Induction in rhesus macaques of GAG- or NEF-specific cytotoxic T lymphocytes by lipopeptides.
    Bourgault I, Chirat F, Tartar A, Lévy JP, Guillet JG, Venet A.
    J Immunol; 1994 Mar 01; 152(5):2530-7. PubMed ID: 8133061
    [Abstract] [Full Text] [Related]

  • 12. Hemagglutinating virus of Japan protein is efficient for induction of CD4+ T-cell response by a hepatitis B core particle-based HIV vaccine.
    Takeda S, Shiosaki K, Kaneda Y, Nakasatomi T, Yoshizaki H, Someya K, Konno Y, Eda Y, Kino Y, Yamamoto N, Honda M.
    Clin Immunol; 2004 Jul 01; 112(1):92-105. PubMed ID: 15207786
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Chimeric HIV-1 virus-like particles containing gp120 epitopes as a result of a ribosomal frameshift elicit Gag- and SU-specific murine cytotoxic T-lymphocyte activities.
    Tobin GJ, Li GH, Fong SE, Nagashima K, Gonda MA.
    Virology; 1997 Sep 29; 236(2):307-15. PubMed ID: 9325238
    [Abstract] [Full Text] [Related]

  • 15. Assembly and extracellular release of chimeric HIV-1 Pr55gag retrovirus-like particles.
    Wagner R, Deml L, Fliessbach H, Wanner G, Wolf H.
    Virology; 1994 Apr 29; 200(1):162-75. PubMed ID: 7510434
    [Abstract] [Full Text] [Related]

  • 16. The majority of currently circulating human immunodeficiency virus type 1 clade B viruses fail to prime cytotoxic T-lymphocyte responses against an otherwise immunodominant HLA-A2-restricted epitope: implications for vaccine design.
    Altfeld M, Allen TM, Kalife ET, Frahm N, Addo MM, Mothe BR, Rathod A, Reyor LL, Harlow J, Yu XG, Perkins B, Robinson LK, Sidney J, Alter G, Lichterfeld M, Sette A, Rosenberg ES, Goulder PJ, Brander C, Walker BD.
    J Virol; 2005 Apr 29; 79(8):5000-5. PubMed ID: 15795285
    [Abstract] [Full Text] [Related]

  • 17. Construction and characterization of recombinant VLPs and Semliki-Forest virus live vectors for comparative evaluation in the SHIV monkey model.
    Notka F, Stahl-Hennig C, Dittmer U, Wolf H, Wagner R.
    Biol Chem; 1999 Mar 29; 380(3):341-52. PubMed ID: 10223337
    [Abstract] [Full Text] [Related]

  • 18. Cellular and humoral immune responses to a canarypox vaccine containing human immunodeficiency virus type 1 Env, Gag, and Pro in combination with rgp120.
    AIDS Vaccine Evaluation Group 022 Protocol Team.
    J Infect Dis; 2001 Feb 15; 183(4):563-70. PubMed ID: 11170981
    [Abstract] [Full Text] [Related]

  • 19. Cytolytic T lymphocytes (CTLs) from HIV-1 subtype C-infected Indian patients recognize CTL epitopes from a conserved immunodominant region of HIV-1 Gag and Nef.
    Thakar MR, Bhonge LS, Lakhashe SK, Shankarkumar U, Sane SS, Kulkarni SS, Mahajan BA, Paranjape RS.
    J Infect Dis; 2005 Sep 01; 192(5):749-59. PubMed ID: 16088824
    [Abstract] [Full Text] [Related]

  • 20. Multiple CTL specificities against autologous HIV-1-infected BLCLs.
    Ahearne PM, Morgan RA, Sebastian MW, Bolognesi DP, Weinhold KJ.
    Cell Immunol; 1995 Mar 01; 161(1):34-41. PubMed ID: 7867083
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 16.